ArticleThe Lancet. Infectious diseases2025

Antiviral activity of tecovirimat against monkeypox virus clades 1a, 1b, 2a, and 2b.

Jeanne Postal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.